Clinical Trial Update: A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis [Phase 2, Phase 3]

View source ↗

Summary

A pilot study evaluating a combination of mesenchymal stem cell infusion (MSCs Iufusion) and etanercept for ankylosing spondylitis, spanning Phase 2 and Phase 3…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Etanercept (etanercept)
• MSCs Iufusion

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Spondylitis, Spondylitis, Ankylosing | Phase 2, Phase 3 | Status: UNKNOWN